Keyphrases
Benign Prostatic Hyperplasia
96%
Prostate Cancer
93%
Reductase
85%
Methylation
77%
Sequence Specificity
58%
Metformin
57%
Prostate
55%
Tumor Necrosis Factor-α
53%
Zorro
45%
Type 2 Diabetes Mellitus (T2DM)
45%
Bladder Pain Syndrome
45%
SRD5A2
45%
Locked nucleic Acid
45%
Urinary Bladder
45%
Advanced Prostate Cancer
43%
Prostate Cancer Patients
42%
Diabetes
39%
Castration-resistant Prostate Cancer
38%
Cancer Cells
36%
TNFRI
34%
Personalized Therapy
34%
Plasmid
31%
Peptide nucleic Acid
31%
Promoter Region
30%
NF-B
29%
5α-reductase Inhibitors
28%
Human Adult
28%
Papillary
28%
Prostate Tissue
27%
Strand Invasion
26%
Benign Prostatic
26%
Tumor
25%
Apoptosis
25%
Epithelial Cells
22%
Chemotherapy Resistance
22%
FBXL10
22%
Specific Gene Silencing
22%
Mixed Linear
22%
Supercoiled Plasmid DNA
22%
Diabetic Bladder Dysfunction
22%
Tumor Heterogeneity
22%
Alternate Pathway
22%
N-cadherin
22%
High-grade Prostate Cancer
22%
Functional Entities
22%
Oestrogenic
22%
Urothelial Dysplasia
22%
Prostate Cancer Progression
22%
Cancer Therapeutics
22%
Tumor Microenvironment
22%
Medicine and Dentistry
Prostate Hypertrophy
100%
Promoter Region
94%
Prostate Cancer
91%
Methylation
90%
Oxidoreductase
85%
Bladder
61%
Personalized Medicine
51%
Precursor
45%
Epithelial Cell
32%
Glycon
30%
Prostate Tissue
29%
Hyperplasia
29%
Castration Resistant Prostate Cancer
28%
Tumor Necrosis Factor
27%
Cancer Growth
26%
Maturity Onset Diabetes of the Young
25%
Telomerase Reverse Transcriptase
22%
Programmed Cell Death
22%
DNA (Cytosine 5) Methyltransferase 1
22%
Mucinous Carcinoma
22%
Androgen Deprivation Therapy
22%
Mediator
22%
Tumor Microenvironment
22%
Fibroblast Growth Factor Receptor 3
22%
Steroid 5alpha Reductase
22%
Bladder Dysfunction
22%
Tumor
22%
Protein Expression
21%
Hazard Ratio
15%
Dysplasia
14%
Somatomedin C
13%
Pathologist
13%
Gleason Score
13%
Diseases
13%
Cytosine
13%
Guanine
13%
Malignant Neoplasm
12%
Diabetes
12%
Tumour Heterogeneity
11%
Urinary System
10%
Cell Signaling Pathway
10%
Biological Marker
9%
Targeted Therapy
9%
Transitional Cell Carcinoma
9%
Gene Promoter
9%
Body Mass Index
9%
Immunoreactivity
9%
Receptor
9%
Prostate Specific Antigen
8%
Neoplasm
8%
Biochemistry, Genetics and Molecular Biology
Reductase
70%
Oxidoreductase
70%
Methylation
51%
Plasmid
51%
Epigenetics
48%
Locked Nucleic Acid
45%
Promoter Region
44%
Peptide Nucleic Acid
38%
Tumor Necrosis Factor
27%
Nucleic Acid
26%
DNA Methyltransferase
22%
RNA Polymerase III
22%
Insulin-Like Growth Factor 1
22%
C-Fos
22%
Transcription
22%
SRD5A2
22%
TRAIL
22%
F-Box Protein
22%
Programmed Cell Death
22%
Gene Inactivation
22%
Insulin-Like Growth Factor 1 Receptor
19%
Protein Expression
18%
Genetics
15%
Enzyme
11%
Oligonucleotide
11%
Gene Therapy
11%
Cell Proliferation
11%
in Vivo Gene Transfer
11%
Secretion (Process)
11%
Infancy
11%
Cationic Lipid
11%
Tumor Necrosis Factor Alpha
11%
Genetic Transcription
11%
Mouse Model
10%
Small Hairpin RNA
10%
Polymerase
10%
Small Interfering RNA
10%
Gene Promoter
9%
Body Mass
9%
Immunoreactivity
9%
Cancer Cell
8%
Upregulation
8%
Cell Cycle
7%
Clinical Trial
7%
DNA Methylation
7%
Fibroblast
7%
Prostate-Specific Antigen
6%
Aromatase
5%
AP-1 Transcription Factor
5%
Hyperglycemia
5%
